Veracyte (VCYT) 8-K/AConsolidated Financial Statements

Filed: 17 Apr 24, 4:34pm

Free signup for more

Track your favorite companies
Receive email alerts for new filings
Personalized dashboard of news and more
Access all data and search results

Search this filing

All

Tables only

Footnotes only

Pre-defined:

Table of contents

Filing tables

Export all tables to Excel

Filing exhibits

8-K/A Current report
23.1 EX-23.1
99.1 EX-99.1
99.2 EX-99.2
Download Excel data file
View Excel data file

VCYT similar filings

4 Sep 24 Departure of Directors or Certain Officers
13 Jun 24 Departure of Directors or Certain Officers
7 May 24 Veracyte Announces First Quarter 2024 Financial Results
17 Apr 24 Consolidated Financial Statements
29 Feb 24 Other Events
22 Feb 24 Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results
13 Feb 24 Departure of Directors or Certain Officers

Filing view

Default size S M L
Default font Times Arial

External links

View on EDGAR (sec.gov)

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in the following Registration Statements:

(1)Registration Statements (Form S-8 Nos. 333-191992, 333-203097, 333-210185, 333-216388, 333-223292, 333-229848, 333-236630, 333-253363, 333-263116, and 333-270147) pertaining to the 2008 Stock Plan, 2013 Stock Incentive Plan, and 2023 Equity Incentive Plan of Veracyte, Inc.;

(2)Registration Statement (Form S-8 No. 333-277552) pertaining to the C2i Genomics, Inc. 2019 Stock Incentive Plan of Veracyte, Inc.;

(3)Registration Statements (Form S-8 Nos. 333-205206 and 333-240214) pertaining to the Amended and Restated Employee Stock Purchase Plan of Veracyte, Inc.; and

(4)Registration Statement (Form S-3 No. 333-277529) of Veracyte, Inc.

of our report dated April 16, 2024, with respect to the consolidated financial statements of C2i Genomics, Inc. as of and for the year ended December 31, 2023, included in this Current Report on Form 8-K/A.

/s/ KOST FORER GABBAY & KASIERER


Tel Aviv, Israel			KOST FORER GABBAY & KASIERER
April 16, 2024			A Member of EY Global

Resources

Knowledgebase
Log In
Register

Company

About
Contact
Solutions

Products

Deal Roadshow
DealVDR
Evercall
Finsight.com

CapEdge

Earnings Calendar
Earnings Transcripts
EDGAR Filing Screener
IPO Calendar

Compliance
Privacy
Security
Terms

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.